These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 7964945

  • 21. The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix.
    de Bruijn HW, Duk JM, van der Zee AG, Pras E, Willemse PH, Boonstra H, Hollema H, Mourits MJ, de Vries EG, Aalders JG.
    Tumour Biol; 1998; 19(6):505-16. PubMed ID: 9817980
    [Abstract] [Full Text] [Related]

  • 22. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
    Cheng XD, Lü WG, Ye F, Chen HZ, Xie X.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
    [Abstract] [Full Text] [Related]

  • 23. [Clinical significance of serum squamous cell carcinoma antigen in the diagnosis, treatment and prognosis of cervical squamous cell carcinoma].
    Luan XM, Zhang Y, Wang SZ, Wang N, Li W, Zhang Q, Wei H, Zhang SL.
    Zhonghua Yi Xue Za Zhi; 2012 May 22; 92(19):1330-3. PubMed ID: 22883121
    [Abstract] [Full Text] [Related]

  • 24. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A, Tana R, Cosio S, Genazzani AR.
    Crit Rev Oncol Hematol; 2008 Apr 22; 66(1):10-20. PubMed ID: 17964182
    [Abstract] [Full Text] [Related]

  • 25. The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy.
    Yoon SM, Shin KH, Kim JY, Seo SS, Park SY, Kang S, Cho KH.
    Int J Gynecol Cancer; 2007 Apr 22; 17(4):872-8. PubMed ID: 17343571
    [Abstract] [Full Text] [Related]

  • 26. Comparison of clinical behaviors and responses to radiation between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas of the cervix.
    Hong JH, Tsai CS, Wang CC, Lai CH, Chen WC, Lee SP, Chang TC, Tseng CJ.
    Chang Gung Med J; 2000 Jul 22; 23(7):396-404. PubMed ID: 10974754
    [Abstract] [Full Text] [Related]

  • 27. Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer.
    Hsieh CY, Chang DY, Huang SC, Yen ML, Juang GT, Ouyang PC.
    Taiwan Yi Xue Hui Za Zhi; 1989 Aug 22; 88(8):797-800. PubMed ID: 2592943
    [Abstract] [Full Text] [Related]

  • 28. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.
    Esajas MD, Duk JM, de Bruijn HW, Aalders JG, Willemse PH, Sluiter W, Pras B, ten Hoor K, Hollema H, van der Zee AG.
    J Clin Oncol; 2001 Oct 01; 19(19):3960-6. PubMed ID: 11579117
    [Abstract] [Full Text] [Related]

  • 29. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
    Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Gunji Y, Kobayashi S, Hayashi H, Ochiai T.
    Surgery; 2003 May 01; 133(5):486-94. PubMed ID: 12773976
    [Abstract] [Full Text] [Related]

  • 30. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence.
    Rose PG, Baker S, Fournier L, Nelson BE, Hunter RE.
    Am J Obstet Gynecol; 1993 Mar 01; 168(3 Pt 1):942-6. PubMed ID: 8456907
    [Abstract] [Full Text] [Related]

  • 31. Cancer of the uterine cervix: clinical value of squamous cell carcinoma antigen (SCC) measurements.
    Lozza L, Merola M, Fontanelli R, Stefanon B, Seregni E, Bombardieri E, De Palo G.
    Anticancer Res; 1997 Mar 01; 17(1B):525-9. PubMed ID: 9066575
    [Abstract] [Full Text] [Related]

  • 32. The role of pretreatment squamous cell carcinoma antigen in predicting nodal metastasis in early stage cervical cancer.
    Lin H, ChangChien CC, Huang EY, Tseng CW, Eng HL, Huang CC.
    Acta Obstet Gynecol Scand; 2000 Feb 01; 79(2):140-4. PubMed ID: 10696963
    [Abstract] [Full Text] [Related]

  • 33. Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.
    Bae SN, Namkoong SE, Jung JK, Kim CJ, Park JS, Kim JW, Lee JM, Kim SJ.
    Gynecol Oncol; 1997 Mar 01; 64(3):418-24. PubMed ID: 9062143
    [Abstract] [Full Text] [Related]

  • 34. Preoperative SCC-Ag as a predictive marker for the use of adjuvant chemotherapy in cervical squamous cell carcinoma with intermediate-risk factors.
    Guo HT, Bi XH, Lei T, Lv X, Yao G, Chen Y, Liu C.
    BMC Cancer; 2020 May 19; 20(1):441. PubMed ID: 32429859
    [Abstract] [Full Text] [Related]

  • 35. Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
    Hirakawa M, Nagai Y, Inamine M, Kamiyama K, Ogawa K, Toita T, Murayama S, Aoki Y.
    Gynecol Oncol; 2008 Jan 19; 108(1):126-9. PubMed ID: 17936344
    [Abstract] [Full Text] [Related]

  • 36. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix.
    Gocze PM, Vahrson HW, Freeman DA.
    Oncology; 1994 Jan 19; 51(5):430-4. PubMed ID: 8052484
    [Abstract] [Full Text] [Related]

  • 37. Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study.
    Gadducci A, Cosio S, Zola P, Tisi G, Ferrero A, Piovano E, Cristofani R, Greco C, Sartori E.
    Int J Gynecol Cancer; 2010 Nov 19; 20(8):1399-404. PubMed ID: 21051984
    [Abstract] [Full Text] [Related]

  • 38. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q, Liu S, Liu H, Zhang J, Guo S, Wang L.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb 19; 50(2):131-6. PubMed ID: 25877611
    [Abstract] [Full Text] [Related]

  • 39. Pretreatment serum CYFRA 21-1 level correlates significantly with survival of cervical cancer patients: a multivariate analysis of 506 cases.
    Piao X, Kong TW, Chang SJ, Paek J, Chun M, Ryu HS.
    Gynecol Oncol; 2015 Jul 19; 138(1):89-93. PubMed ID: 25913134
    [Abstract] [Full Text] [Related]

  • 40. SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer.
    van de Lande J, Davelaar EM, von Mensdorff-Pouilly S, Water TJ, Berkhof J, van Baal WM, Kenemans P, Verheijen RH.
    Gynecol Oncol; 2009 Jan 19; 112(1):119-25. PubMed ID: 19007978
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.